About this resource:

Systematic Review

Source: U.S. Preventive Services Task Force

Last Reviewed: June 2019

Workgroups: HIV Workgroup

The U.S. Preventive Services Task Force (USPSTF) recommends that health care providers offer pre-exposure prophylaxis (PrEP) combined with effective antiretroviral therapy to people who are at risk of getting HIV (human immunodeficiency virus). Specifically, USPSTF recommends the PrEP formulation that's approved by the U.S. Food and Drug Administration for people who meet at least 1 of these criteria:

  • Inject drugs and share injection equipment
  • Have sex with someone who might have HIV
  • Don't consistently use a condom during sex
  • Were diagnosed with a sexually transmitted infection in the past month
Read more about this resource

Objectives related to this resource (1)

Suggested Citation


U.S. Preventive Services Task Force. (2019). Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis. Retrieved from https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis